Federal Reserve chairman Ben Bernanke has once again allayed fears of a double-dip recession saying the US is staging a "moderate economic recovery".
Euphoria over a joint EU-IMF rescue deal for Greece worth €45bn (£39.8bn) appears short-lived, after angry reactions in Germany and continued concerns among bond investors any bail-out merely delays the worst.
Historic decision is expected to improve the prospects for many US biotech and pharmaceutical companies
ProFunds Group has launched a range of single inverse ProShares ETFs in the US, providing exposure to China, US real estate and the US basic materials sector.
While the outlook for the market remains uncertain, the US recovery is showing clear signs of progression.
Management teams of US companies appear to be in wait-and-see mode as they can still see several hurdles the economy needs to get over in order to ensure future growth.
F&C's Fatima Luis is boosting exposure to floating rate notes as a protection against rising rates.